Federal Judge Dismisses 150 Pelvic Mesh Lawsuits Against C.R. Bard
A West Virginia federal judge yesterday dismissed nearly 150 product liability lawsuits brought against C.R. Bard (NYSE:BCR) over its pelvic mesh products, after an appeals court earlier this year upheld a $2 million verdict against the company in another suit.
Judge Joseph Goodwin of the U.S. District Court for Southern West Virginia, who’s overseeing the multi-district litigation involving thousands of lawsuits filed against Bard and other mesh makers, dismissed 149 of suits yesterday, according to court documents. The devices are designed to treat female urinary incontinence and pelvic organ prolapse. Medtronic (NYSE:MDT) subsidiary Covidien, which supplied the mesh to Bard, was also included in the dismissals.
Judge Joseph Goodwin of the U.S. District Court for Southern West Virginia, who’s overseeing the multi-district litigation involving thousands of lawsuits filed against Bard and other mesh makers, dismissed 149 of suits yesterday, according to court documents. The devices are designed to treat female urinary incontinence and pelvic organ prolapse. Medtronic (NYSE:MDT) subsidiary Covidien, which supplied the mesh to Bard, was also included in the dismissals.